Por Renan Filho · 2026-09-28The U.S. Department of Justice (DOJ) has formally petitioned the Supreme Court to review a federal appeals court decision that struck down a ban on transgender medical treatments for inmates in federal prisons. The policy, introduced in early 2025, prohibits the Bureau of Prisons from providing sex reassignment surgeries or cross-sex hormone therapy to transgender individuals incarcerated in federal facilities. In a filing submitted last week, the DOJ argued that the ban is a reasonable exercise of administrative discretion, grounded in fiscal responsibility, prison safety, and the limited role of government in funding non-essential medical procedures.
The legal battle began when several transgender inmates sued, claiming that denial of treatment violates the Eighth Amendment’s prohibition against cruel and unusual punishment. In late 2025, the Ninth Circuit Court of Appeals ruled in their favor, stating that the ban constitutes deliberate indifference to serious medical needs. The appeals court cited expert testimony asserting that gender-affirming care is medically necessary and that withholding it causes severe psychological harm. The DOJ’s petition, filed with the Supreme Court on September 25, 2026, argues that the lower court overstepped its judicial mandate by substituting its own medical judgment for that of corrections officials. The department emphasizes that federal prisons are not healthcare providers, and that the government has a compelling interest in minimizing costs and ensuring institutional order.
This case arrives at a time when transgender rights are hotly contested across the nation. Several conservative states have enacted similar bans on Medicaid funding for gender-affirming care, and the Supreme Court has yet to rule definitively on the constitutional status of such treatments. The DOJ’s petition frames the issue as one of federalism and separation of powers, asserting that prison administrators must retain flexibility to allocate scarce resources. The filing also points to a 2024 Supreme Court decision that allowed states to ban transgender surgeries for minors, suggesting that public funding for such procedures is not a settled right.
From a FORTIS perspective, this petition deserves cautious support. Our editorial stance favors limited government and individual liberty, but we also recognize that liberty does not automatically entail government subsidy. The Constitution guarantees freedom from cruel and unusual punishment, not a right to elective medical procedures funded by taxpayers. Estimates place the cost of a single gender reassignment surgery at over $200,000, with hormone therapy running thousands of dollars annually per inmate. When federal prisons face chronic overcrowding and staffing shortages, diverting funds to these procedures undermines the core mission of public safety. Moreover, safety concerns are legitimate: prison officials have reported that transgender inmates can pose unique security risks, and the presence of surgical-recovery units can disrupt facility operations. The Ninth Circuit’s ruling effectively imposes a one-size-fits-all medical policy on a system that demands individualized discretion.
Critics will argue that denying care violates basic human dignity and could lead to self-harm or suicide among transgender inmates. But the DOJ’s petition does not propose banning all care; rather, it objects to coercively requiring the government to provide irreversible, costly interventions. The proper venue for such decisions is the legislative and executive branches, where budget priorities and medical standards are debated with public input. Courts should not be in the business of mandating specific treatments under the guise of constitutional interpretation. The Supreme Court should grant certiorari and clarify that the Eighth Amendment does not compel governments to fund gender-affirming procedures in prisons, just as it does not require them to fund cosmetic surgery or experimental treatments.